Rollout of COVID antibody therapy requires clinician feedback, U.S. officials say
By
Alicia Lasek
Nov 11, 2020
Federal agencies say they will depend on clinician input during distribution of Eli Lilly’s new intravenous antibody therapy for high-risk COVID-19 patients.
CMS offers a deal to hospitals to cut Medicare appeals backlog
By
Tim Mullaney
Sep 03, 2014
In an effort to trim the huge backlog of Medicare claims appeals that has stymied long-term care and other providers, the government is offering a new way to settle some cases. Hospitals could receive...
